Transplantation News

BOSTON — Patients randomized to early withdrawal of corticosteroids after a living or deceased donor transplant had near-identical outcomes to patients who continued corticosteroids, according to a study presented here.

BOSTON — Kidneys from donors aged 70 years or older were effective in transplantation and should be considered for the procedure, according to results of a poster presented at the American Transplant Congress.

BOSTON — For deceased donor transplants, AKI in the donor did not have any negative impact on eGFR in the recipient at 1 year, according to a poster presented at the American Transplant Congress.

BOSTON — In the past 3 decades, survival rates of both allograft and patients following kidney transplant have improved, according to a speaker at the American Transplant Congress.

BOSTON — Kidney transplant recipients with a failing graft had an increased risk for both mortality and morbidity compared to patients who had a similar degree of kidney dysfunction but no transplant, according to a speaker at the American Transplant Congress.

BOSTON — Due to a variety of social determinants — including age, race and socioeconomic status — women have less access to kidney transplantation than men, according to a speaker at the American Transplant Congress.

A study by Drexel University researchers indicates the risk of more hospitalizations and death for kidney transplant patients increases for patients asked to lose 10% or more of their weight prior to the transplant.

CMS issued a final rule on May 16 that will continue to allow, at least for now, transplant physicians to prescribe most anti-rejection transplant drugs through the Medicare Part D drug formulary.

BOSTON — Kidney transplant recipients from underserved communities have limited access to healthy foods and high levels of stress and anxiety, which contribute to a likelihood of weight gain post-transplant, according to results of a poster presented at the National Kidney Foundation Spring Clinical Meetings.

A new HHS report estimates that Medicare would save $73 million during the course of 10 years if Congress extends coverage of immunosuppressive drugs beyond the current 3 years post-transplant.